Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Parexel and Palantir Expand Collaboration to Accelerate Clinical Data Delivery and Power Clinical Outcomes for Patients
Friday, April 26, 2024Parexel one of the worlds largest clinical research organizations providing the full range of Phase I to IV clinical development services and Palantir Technologies Inc a leading builder of Artificial Intelligence systems today announced a multiyear
Starton Therapeutics Announces Enrollment Completion for STAR-LLD Phase 1b Clinical Trial in Multiple Myeloma
Friday, April 26, 2024Starton Therapeutics Inc a clinicalstage biotechnology company transforming standardofcare therapies with proprietary dermal technologies announced today the successful completion of enrollment for its STARLLD Phase b clinical trial
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
Thursday, April 25, 2024Arrowhead Pharmaceuticals Inc announced today that it has dosed the first subjects in a Phase a clinical trial of AROCFB the companys investigational RNA interference therapeutic in up to healthy volunteers and patients with complement
Bioaffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
Thursday, April 25, 2024BioAffinity Technologies Inc a biotechnology company focused on the need for noninvasive accurate tests for the detection of earlystage lung cancer and other lung diseases today announced David Elzi PhD has been named Vice President
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
Wednesday, April 24, 2024Palisade Bio Inc a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune inflammatory and fibrotic diseases today announced it has entered
Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Wednesday, April 24, 2024Medicure Inc a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market announced today that through its subsidiary Medicure
NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease
Tuesday, April 23, 2024NeuroSense Therapeutics Ltd a company developing novel treatments for severe neurodegenerative diseases announced today a collaboration in Alzheimers Disease drug development with Genetika
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Tuesday, April 23, 2024Pfizer Inc today announced that the European Commission has granted marketing authorization for EMBLAVEO for the treatment of adult patients
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
Tuesday, April 23, 2024Lexeo Therapeutics Inc a clinical stage genetic medicine company today announced an inlicense agreement with Cornell University to expedite
Ipsen and Skyhawk Therapeutics Announce RNA Targeting Research Collaboration in Rare Neurological Diseases
Monday, April 22, 2024Ipsen and Skyhawk Therapeutics today announced the signing of an exclusive worldwide collaboration to discover and develop novel small molecules that modulate RNA for rare neurological diseases
